发布求助
文献互助 智能选刊 最新文献

Alcoholism & Drug Abuse Weekly最新文献

筛选
英文 中文
Survey finds greater support for rights of people with physical disabilities than with mental illness or SUD 调查发现身体残疾人士的权利比精神疾病或精神障碍人士得到更多的支持
Alcoholism & Drug Abuse Weekly Pub Date : 2026-10-16 DOI: 10.1002/adaw.35082
Alison Knopf
{"title":"Survey finds greater support for rights of people with physical disabilities than with mental illness or SUD","authors":"Alison Knopf","doi":"10.1002/adaw.35082","DOIUrl":"https://doi.org/10.1002/adaw.35082","url":null,"abstract":"<p>A recent survey found that there is more support for the rights of people with physical disabilities than compared with people with mental illness or substance use disorders. The study, “Support for Human and Civil Rights in Physical Disability, Mental Illness, and Substance Use,” was published online in <i>JAMA Health Forum</i> on October 2.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 40","pages":"6-7"},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse outcomes of psychedelics self-reported: Survey 自述致幻剂的不良后果：调查
Alcoholism & Drug Abuse Weekly Pub Date : 2026-10-16 DOI: 10.1002/adaw.35083
Alison Knopf
{"title":"Adverse outcomes of psychedelics self-reported: Survey","authors":"Alison Knopf","doi":"10.1002/adaw.35083","DOIUrl":"https://doi.org/10.1002/adaw.35083","url":null,"abstract":"<p>A nationally representative cross-sectional survey of U.S. adults found the among all psychedelics, ibogaine and 5-MeO-DMT (5-methoxy-N,N- dimethyltryptamine) resulted in the most frequent self-reported adverse outcomes, according to a recent study. The study, “Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT,” by Otto Simonsson, Ph.D., and colleagues, was published September 20 in <i>JAMA Network Open.</i> The number of adults reporting adverse outcomes was greatest for psilocybin, LSD (lysergic acid diethylamide) and MDMA (methylenedioxymethamphetamine), because these substances are more commonly used. Many findings have indicated risks of cardiac adverse effects of ibogaine, consistent with its known association with QTc prolongation and arrhythmia. The study researchers said the information is important, as psychedelics such as psilocybin, LSD MDMA are in clinical trials for psychiatric disorders. Ibogaine and 5-MeO-DMT have also shown promise for psychiatric disorders in smaller trials. The study's researchers conducted a survey of 1,964 adults. Past 12-month use was reported by 1,151 respondents for psilocybin, 376 for LSD, 539 for MDMA, 74 for ibogaine and 95 for 5-MeO-DMT. The study limitations included the cross-sectional design, which precluded conclusions about causality.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 40","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benzodiazepine tapering a year later 一年后苯二氮卓类药物逐渐减少
Alcoholism & Drug Abuse Weekly Pub Date : 2026-10-16 DOI: 10.1002/adaw.35080
Alison Knopf
{"title":"Benzodiazepine tapering a year later","authors":"Alison Knopf","doi":"10.1002/adaw.35080","DOIUrl":"https://doi.org/10.1002/adaw.35080","url":null,"abstract":"<p>The American Society of Addiction Medicine (ASAM) last year released a new guideline, in collaboration with nine other professional societies, on when and how to taper and discontinue benzodiazepines.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 40","pages":"3-4"},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longer duration of MOUD during and after pregnancy lowers OD and death risk: Study 研究：怀孕期间和怀孕后更长时间的mod可以降低OD和死亡风险
Alcoholism & Drug Abuse Weekly Pub Date : 2026-10-16 DOI: 10.1002/adaw.35079
Alison Knopf
{"title":"Longer duration of MOUD during and after pregnancy lowers OD and death risk: Study","authors":"Alison Knopf","doi":"10.1002/adaw.35079","DOIUrl":"https://doi.org/10.1002/adaw.35079","url":null,"abstract":"<p>The longer that pregnant women with opioid use disorder (OUD) remain on medication for OUD (MOUD), the lower their risk of death and overdose during the first postpartum year, researchers have found. In “Duration of Medication Use for Opioid Use Disorder and Risk of Postpartum Overdose and Death,” published October 1 in <i>JAMA Network Open</i>, researchers from Vanderbilt University and Emory University found that 9,360 pregnancies among 7,776 individuals found that those with a greater days' supply of MOUD were less likely to have nonfatal overdose and death. The study's lead author is Ahra Kim, MPH.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 40","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coming Up… 上来……
Alcoholism & Drug Abuse Weekly Pub Date : 2026-10-16 DOI: 10.1002/adaw.35085
{"title":"Coming Up…","authors":"","doi":"10.1002/adaw.35085","DOIUrl":"https://doi.org/10.1002/adaw.35085","url":null,"abstract":"<p>The 2026 <b>California Society of Addiction Medicine</b> (CSAM) annual conference will be held <b>October 21-24</b> in Garden Grove, California. For more information, go to https://www.csam-asam.org/events/2026-annual-conference</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 40","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OASAS at InUnity: Challenges and victories in the SUD world InUnity的OASAS：在SUD世界的挑战和胜利
Alcoholism & Drug Abuse Weekly Pub Date : 2026-10-16 DOI: 10.1002/adaw.35078
Alison Knopf
{"title":"OASAS at InUnity: Challenges and victories in the SUD world","authors":"Alison Knopf","doi":"10.1002/adaw.35078","DOIUrl":"https://doi.org/10.1002/adaw.35078","url":null,"abstract":"<p>Last week's conference of the InUnity Alliance featured the New York Office of Addiction Services and Supports (OASAS) as well as the Office of Mental Health (OMH) in reporting on victories — a 44% reduction in overdose deaths — and the challenges of health services of New York. Co-occurring mental illness and substance use disorder (SUD), an increase in stimulant-related overdose deaths, online sports betting, upcoming Medicaid work requirements, and lack of an adequate workforce were among the discussed challenges.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 40","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Starset: Reimbursement partnership between NAATP and Third Horizon Starset: NAATP和Third Horizon之间的报销伙伴关系
Alcoholism & Drug Abuse Weekly Pub Date : 2026-10-16 DOI: 10.1002/adaw.35084
Alison Knopf
{"title":"Starset: Reimbursement partnership between NAATP and Third Horizon","authors":"Alison Knopf","doi":"10.1002/adaw.35084","DOIUrl":"https://doi.org/10.1002/adaw.35084","url":null,"abstract":"<p>Providers now have an easier way to find out how much commercial insurance will reimburse them. Last week the National Association of Addiction Treatment Providers (NAATP) and Third Horizon today announced an expansion of their reimbursement benchmarking partnership with the launch of Third Horizon's Starset Rate Compass. This is an interactive platform thatsheds light on published negotiated commercial rates for substance use disorder (SUD) and mental health services in every state. Rate Compass builds on the initial NAATP Addiction Treatment National Rate Benchmark Report, released to members in December 2025 as the first national analysis of commercial reimbursement for facility-based addiction treatment.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 40","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Case You Haven't Heard… 如果你还没听说过……
Alcoholism & Drug Abuse Weekly Pub Date : 2026-10-09 DOI: 10.1002/adaw.35077
{"title":"In Case You Haven't Heard…","authors":"","doi":"10.1002/adaw.35077","DOIUrl":"https://doi.org/10.1002/adaw.35077","url":null,"abstract":"<p>To the ever constant complaints that methadone is hard to get because patients have to go to the clinic every day, this is a reminder: They don't. For years, patients have been able to access the medication on a take-home basis for a month, and even for up to two weeks, even if they are unstable. In addition, there are an increasing number of mobile vans. Leading the way is CODAC Behavioral Healthcare, which just recently brought its mobile van to the coastal town of Westerly, Rhode Island, which Taylor Swift calls home. We have been to this beautiful town. Like all beautiful towns, it has people with opioid use disorder who need treatment. Let's champion programs like this instead of trying to take down the entire methadone treatment system. Thanks to Linda Hurley and her team at CODAC. For more on the program, go to https://alisonknopf.substack.com/. Could access to methadone be easier and simpler? Yes. It would help if people would stop badmouthing the treatment.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 39","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149146700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Grateful Journey! 感恩之旅！
Alcoholism & Drug Abuse Weekly Pub Date : 2026-10-09 DOI: 10.1002/adaw.35073
Rob Kent Esq.
{"title":"A Grateful Journey!","authors":"Rob Kent Esq.","doi":"10.1002/adaw.35073","DOIUrl":"https://doi.org/10.1002/adaw.35073","url":null,"abstract":"<p>“Gratitude unlocks the fullness of life. It turns what we have into enough, and more. It turns denial into acceptance, chaos to order, confusion to clarity. It can turn a meal into a feast, a house into a home, a stranger into a friend. Gratitude makes sense of our past, brings peace for today and creates a vision for tomorrow.” ― the late Melody Beattie, recovery and self-help advocate</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 39","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149146701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Youth with OUD unlikely to get methadone, buprenorphine, or ER naltrexone: Study 患有OUD的青少年不太可能服用美沙酮、丁丙诺啡或ER纳曲酮：研究
Alcoholism & Drug Abuse Weekly Pub Date : 2026-10-09 DOI: 10.1002/adaw.35072
Alison Knopf
{"title":"Youth with OUD unlikely to get methadone, buprenorphine, or ER naltrexone: Study","authors":"Alison Knopf","doi":"10.1002/adaw.35072","DOIUrl":"https://doi.org/10.1002/adaw.35072","url":null,"abstract":"<p>Only 1 in 32 youths with opioid use disorder (OUD) who are Medicaid recipients received sustained pharmacotherapy, and most did not receive timely treatment at all, a study's researchers have found. The study, by Scott E. Hadland, M.D., and colleagues, was published online October 2 in <i>JAMA Network Open</i>. It concludes that persistent disparities occur for youths of color.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 39","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149146275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书